15/08/2023
🌟 Exciting News Alert! 🌟 The FDA has given the green light to zuranolone, a breakthrough short-term oral medication designed to support new parents battling postpartum depression. 💙✨ Classified as an antidepressant, this game-changing drug is to be taken daily for just 2 weeks, offering hope and relief.
🌼 Developed by Biogen, zuranolone has shown incredible promise in trials, with noticeable improvement in depression symptoms for new moms in as little as 3 days after starting treatment. 🌈💪
Mark your calendars: Commercial availability of Zurzuvae (zuranolone) is expected by Q4, possibly by October. Let's spread the word and support the mental well-being of new parents everywhere! 🤗👪
The FDA approved zuranolone, a short-term oral medication that could help new parents who are struggling with depression after giving...